Knowledge Center

Patent / Jan 11, 2024

Dry powder inhaler pharmaceutical composition of coated crystalline dry powder for inhalation

Authors:
  • Beatriz Fernandes
  • Filipe Vultos
  • Eunice Costa
Source:
WO 2024009079 A1

The present invention describes a dry powder inhaler pharmaceutical composition comprising one or more active pharmaceutical ingredients (API) coated with one or more force control agents (FCA) with optimized aerodynamic performance by micronizing crystalline API particles to the respirable range and coating the particles with a force control agent. The present invention also id pharmaceutical composition, and its use in medicine.

 

Also in the Knowledge Center

Related Content

Sustainability

At Hovione, sustainability is not just an aspiration - it is a fundamental component of our strategy and daily operations. Embedded deeply within our DNA, sustainability is brought to life by the commitment and actions of every member of our team.

Page
Read more

Particle Engineering for Inhalation and Nasal

Hovione is a global expert and recognized leader in particle engineering, an essential technology when developing inhalation drug products.

Page
Read more

PharmSD 3.0

Redefining Pharmaceutical Spray Drying for a healthier, more resilient future.

Page
Read more